Americans are particularly concerned with avoiding animal products. Indeed, a recent study published in the Postgraduate ...

Huahei Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus (HDV), ...

At the JP Morgan Healthcare conference this year, a lot of the discourse around AI drug discovery focused on making the leap ...

The phase 2 trial of CT-388, a once-weekly subcutaneous injection acquired as part of its $2.7 billion takeover of Carmot ...

Boehringer Ingelheim has added another drug to its immunology pipeline, licensing an inflammatory bowel disease (IBD) ...

The UK has lost its measles elimination status, according to the World Health Organization (WHO), after recording 2,911 ...

In this second of three articles on The Sunday Times top 100 tech companies list, pharmaphorum is focusing on the first nine ...

An international trial has started to see if a simple finger-prick blood test could predict the risk of Alzheimer's disease, before people start showing signs of cognitive decline. The Bio-Hermes-002 ...

A new technology elucidated yesterday in the journal Nature has the potential to be a leap forward in DNA synthesis, allowing ...

NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...

A hole has been blown in Bausch Health's late-stage pipeline, after a follow-up to its top-selling drug product Xifaxan ...